Drugs that Affect Pituitary and Hypothalamic Hormones; Calcium Metabolism Flashcards
Growth Hormone
- Use
- Mechanism of action
- Side effects
- Children: GH deficiency, idiopathic short stature; Adult: GH deficiency, muscle wasting in AIDS
- Human, recombinant
- Peripheral edema, carpal tunnel, impaired glucose tolerance
Sermorelin acetate
- Use
- Mechanism of action
- Side effects
- Children: GH deficiency, idiopathic short stature; Adult: GH deficiency, muscle wasting in AIDS
- Synthetic GHRH analog
- Injection site reactions and headache
IGF-1
- Use
- Mechanism of action
- Side effects
- Syndromes of GH resistance
- Human, recombinant
- Peripheral edema, carpal tunnel, impaired glucose tolerance
Octreotide
- Use
- Mechanism of action
- Side effects
- Acromegaly or gigantism
- Somatostatin agonist: selective for type 2 & 5 somatostatin receptors to inhibit GH release from pituitary
- Nausea, abd pain, gallstones
Ianreotide
- Use
- Mechanism of action
- Side effects
- Acromegaly or gigantism
- Somatostatin agonist: selective for type 2 & 5 somatostatin receptors to inhibit GH release from pituitary
- Nausea, abd pain, gallstones
Pegvisomant
- Use
- Mechanism of action
- Acromegaly or gigantism
2. GH antagonist: binds to GH receptor but doesn’t allow for dimerization so it doesn’t elicit a response
Role of Prolactin
Stimulate lactation and inhibits reproductive functions
**not used as a drug but hyperprolactinemia is treated with dopamine agonists
Bromocriptine
- Use
- Mechanism of action
- Side effects
- Treat hyperprolactinemia causing amenorrhea, galactorrhea and infertility
- Hypothalamic dopamine is an inhibitory factor for prolactin release
- Nausea, headache, orthostatic hypotension
Cabergoline
- Use
- Mechanism of action
- Side effects
- Treat hyperprolactinemia causing amenorrhea, galactorrhea and infertility
- Hypothalamic dopamine is an inhibitory factor for prolactin release
- Nausea, headache, orthostatic hypotension
Oxytocin
- Use
- Mechanism of action
- Induce labor
2. Modulates transmembrane ion currents in the smooth muscle of the myometrium to produce contractions
Vasopressin
- Use
- Mechanism of action
- Replacement therapy in DI of pituitary origin
2. Causes increased reabsorption of water (also vasoconstriction due to nonselective V1 and V2 agonism)
Desmopressin
- Use
- Mechanism of action
- Replacement therapy in DI of pituitary origin
2. Causes increased reabsorption of water (V2 selective)
Vitamin D
- How are active metabolites synthesized?
- Main effect
- Net effect
- Use
- Reactions in the skin, liver, and kidney. Kidney reactions are influenced by PTH (increases enzyme in the kidney that produces active vitamin D)
- Increased absorption of Ca++ from GI
- Increased serum Ca++
- Hypocalcemia
Calcitonin
- Mechanism of action
- Preparations available
- Hormone: made in C cells of thyroid; inhibits bone resorption and causes decreased serum calcium
- salmon or human
- Use: Hypercalcemia
Alendronate
- Use
- Mechanism of action
- Side effects
- Osteoporosis, hypercalcemia
- Linear-nitrogen-containing bisphosphonate: inhibit farnesyl diphosphate synthase –> inhibits cholesterol synthesis –> inhibits osteoclasts, so decreased bone resorption
- Esophagitis, joint, bone, muscle pain, osteonecrosis of the jaw
Ibandronate
- Use
- Mechanism of action
- Side effects
- Osteoporosis, hypercalcemia
- Linear-nitrogen-containing bisphosphonate: inhibit farnesyl diphosphate synthase –> inhibits cholesterol synthesis –> inhibits osteoclasts, so decreased bone resorption
- Esophagitis, joint, bone, muscle pain, osteonecrosis of the jaw
Zoledronate
- Use
- Mechanism of action
- Side effects
- Osteoporosis, hypercalcemia
- Ringed-nitrogen-containing bisphosphonate: inhibit farnesyl diphosphate synthase –> inhibits cholesterol synthesis –> inhibits osteoclasts, so decreased bone resorption
- Esophagitis, joint, bone, muscle pain, osteonecrosis of the jaw
Raloxifene
- Use
- Type of drug
- Osteoporosis
2. Selective Estrogen Receptor Modulator (SERM)
Denosumab
- Use
- Mechanism of action
- Osteoporosis
2. An antibody that inhibits bone resorption by binding RANKL (osteoclast receptor stimulating bone resorption
Tetriparatide
- Use
- Mechanism of action
- Osteoporosis
2. PTH: acts on osteoblasts to stimulate bone formation